Overview
- 38 inspections across 36 sites are on record.
- 60 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
38
Sites
36
Observations
60
Career since
Mar 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Benefit Coatings Inc. | 27 Mar 2026 | Human Drugs | |
| Miyoshi America, Inc | 6 Feb 2026 | Human Drugs | On file |
| Topiox Research Centre Private Limited | 19 Nov 2025 | Human Drugs | |
| Lupin Limited | 14 Nov 2025 | Human Drugs | |
| Innova Pharmactive Private Limited | 7 Nov 2025 | Human Drugs |
Sites inspected
Benefit Coatings Inc.Stratford, United States1 insp.
Miyoshi America, IncDayville, United States1 insp.
Topiox Research Centre Private LimitedNavi Mumbai, India1 insp.
Lupin LimitedNagpur, India1 insp.
Innova Pharmactive Private LimitedNagpur, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Jonah S Ufferfilge5 shared
Sean R Marcsisin2 shared
Luxuly Abraham1 shared
Alisha B Patel1 shared
Raihan A Chowdhury1 shared
Khalid M Khan1 shared
Christian F Gomez Lugo1 shared
Paige R Mccoy1 shared
Evan Tong1 shared
Jazmine N Brown1 shared
Full investigator report
Get the verbatim findings behind Samir C Gala's 60 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site